What sector does Solventum belong to?

Solventum operates in the Health Care sector, specifically the Health Care Technology industry, and is listed on the US markets.

What is the current share price of SOLV?

As of the latest available quote, SOLV traded at $87.45. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of SOLV?

Solventum has a price-to-earnings (P/E) ratio of about 10.69. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of SOLV?

The market capitalisation of Solventum is approximately $15.32B.

Is Solventum profitable?

For its latest reported financial year, Solventum recorded a net profit margin of about 18.69%.

Does SOLV pay a dividend?

Solventum does not currently show a dividend yield in our data.

What is the return on equity (ROE) of SOLV?

Solventum has a return on equity (ROE) of about 32.42%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of SOLV?

Over the past 52 weeks, SOLV has traded between a low of $62.38 and a high of $94.16.

Solventum

SOLV US Health Care Health Care Technology

S&P 500

$87.45

-0.23%

Delayed · cached 15 min

Fair value analysis

SOLV

Solventum

$87.45

Close used for this calculation

$137.56Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

59/100

Profitability15/25

Returns23/25

Balance Sheet3/25

Efficiency18/25

Growth9/25

Good

Quality radar

Consensus fair value

$137.56

Below FV

▲ +57.3% against the close used

Model range $40.05 – $177.60

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear$40.05Fair value$137.56Bull$177.60

FairClose

52-week traded range

52W low $62.4952W high $92.44

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Solventum closed at $87.45, 36.4% below the consensus fair value of $137.56 drawn from 8 valuation models.

Financial DNA score 59/100 — Good. P/E of 9.9x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

$136.15

+55.7%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=4.5%, r=10%, tg=3%, n=10yr

Graham Number

$74.36

-15.0%

√(22.5 × EPS × BVPS)

EPS=8.88, BVPS=27.67 · outside Graham range (P/E 9.9, P/B 3.2) — asset-light, treat as a rough floor

P/E Fair Value

$177.60

+103.1%

EPS × 20x (sector P/E)

EPS=8.88, Sector P/E=20x

Peter Lynch (PEG)

$40.05

-54.2%

EPS × Growth% (PEG = 1 is fair)

EPS=8.88, g=4.5%

EV/EBITDA

$163.01

+86.4%

(EBITDA × 12.3x − Net Debt) ÷ Shares

EBITDA=2.67B

Book Value (P/B)

$140.69

+60.9%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=27.67, ROE=32.4%, g=4.5%, r=10%

Reverse DCF

$87.45

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: -2.5% | Historical: 4.5%

Margin of Safety

$97.03

+11.0%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=129.37, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer